investorscraft@gmail.com

Intrinsic ValueKuraray Co., Ltd. (3405.T)

Previous Close¥1,665.50
Intrinsic Value
Upside potential
Previous Close
¥1,665.50

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Kuraray Co., Ltd. operates as a diversified chemical company with a global footprint, specializing in high-performance materials across multiple segments. Its core business includes the production of functional resins, thermoplastic elastomers, synthetic fibers, and advanced carbon materials, catering to industries such as automotive, construction, healthcare, and textiles. The company’s flagship products, such as PVA, PVB, EVAL films, and SEPTON elastomers, are critical in applications requiring durability, flexibility, and chemical resistance. Kuraray holds a strong position in niche markets, particularly in Japan and Asia, where its technological expertise and vertically integrated operations provide a competitive edge. Its diversified portfolio mitigates sector-specific risks while allowing cross-segment synergies in R&D and production. The company’s focus on high-value functional materials aligns with global trends toward sustainability and advanced material solutions, reinforcing its market relevance.

Revenue Profitability And Efficiency

Kuraray reported revenue of JPY 826.9 billion for FY 2024, with net income of JPY 31.7 billion, reflecting a net margin of approximately 3.8%. Operating cash flow stood at JPY 138.3 billion, indicating solid cash generation despite capital expenditures of JPY 75.8 billion. The company’s profitability metrics suggest moderate efficiency, with room for improvement in cost optimization amid volatile raw material prices and global supply chain challenges.

Earnings Power And Capital Efficiency

The company’s diluted EPS of JPY 96.27 underscores its earnings capability, supported by stable demand for high-performance materials. Operating cash flow coverage of capital expenditures (1.8x) highlights prudent capital allocation, though debt levels (JPY 244.3 billion) relative to cash (JPY 118.1 billion) suggest a balanced but leveraged financial structure. Kuraray’s R&D-driven product differentiation enhances capital efficiency over the long term.

Balance Sheet And Financial Health

Kuraray’s balance sheet reflects a moderate debt load, with total debt of JPY 244.3 billion against cash reserves of JPY 118.1 billion. The net debt position (JPY 126.2 billion) is manageable given its operating cash flow generation. The company’s liquidity appears adequate, but leverage ratios warrant monitoring amid cyclical industry pressures and potential capex increases.

Growth Trends And Dividend Policy

Revenue growth has been steady, supported by demand for functional materials in key sectors. The dividend payout of JPY 54 per share indicates a shareholder-friendly policy, with a yield aligning with industry peers. Future growth may hinge on innovation in sustainable materials and geographic expansion, though macroeconomic headwinds could temper near-term performance.

Valuation And Market Expectations

With a market cap of JPY 579.8 billion and a beta of 0.74, Kuraray is perceived as a relatively stable investment within the chemicals sector. The valuation reflects expectations of gradual growth, with investors likely pricing in its niche market strengths and R&D capabilities rather than aggressive expansion.

Strategic Advantages And Outlook

Kuraray’s strategic advantages lie in its technological expertise, diversified product portfolio, and strong Asian market presence. The outlook remains cautiously optimistic, with opportunities in sustainable materials and high-performance applications offsetting sector volatility. Execution on innovation and cost management will be critical to maintaining competitiveness.

Sources

Company filings, Bloomberg

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount